<description>&lt;p&gt;&lt;span style= "font-size: 10.0pt; line-height: 115%; font-family: 'Trebuchet MS',sans-serif; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"&gt; In this episode of OncTimes Talk, we chat with Dr. Eliot Siegel, MD, FACR, FSIM, DABR; Dr. Michael Morris, MD, MS, DABR, DABNM, DCI; Dr. Babak Saboury, MD, MPH, DABR, DABNM; and Chief Medical Officer Dr. Munir Ghesani, MD, FACNM, FACR, FSNMMI from United Theranostics, a national leader in precision cancer care and radiopharmaceutical therapy.&lt;br /&gt; &lt;br /&gt; Together, these visionary physicians are advancing the frontiers of targeted cancer treatment, bringing innovative therapies and cutting-edge research to patients and communities across the country. We explore the evolution and future of radiopharmaceutical therapy, the challenges and opportunities in expanding access to advanced cancer care, and how United Theranostics is shaping the next generation of oncology practice.&lt;/span&gt;&lt;/p&gt;</description>

OncTimes Talk

Oncology Times

United Theranostics and the Future of Cancer Care

NOV 3, 202569 MIN
OncTimes Talk

United Theranostics and the Future of Cancer Care

NOV 3, 202569 MIN

Description

In this episode of OncTimes Talk, we chat with Dr. Eliot Siegel, MD, FACR, FSIM, DABR; Dr. Michael Morris, MD, MS, DABR, DABNM, DCI; Dr. Babak Saboury, MD, MPH, DABR, DABNM; and Chief Medical Officer Dr. Munir Ghesani, MD, FACNM, FACR, FSNMMI from United Theranostics, a national leader in precision cancer care and radiopharmaceutical therapy. Together, these visionary physicians are advancing the frontiers of targeted cancer treatment, bringing innovative therapies and cutting-edge research to patients and communities across the country. We explore the evolution and future of radiopharmaceutical therapy, the challenges and opportunities in expanding access to advanced cancer care, and how United Theranostics is shaping the next generation of oncology practice.